Overexpression of PTEN suppresses lipopolysaccharide-induced lung fibroblast proliferation, differentiation and collagen secretion through inhibition of the PI3-K-Akt-GSK3beta pathway

Cell and Bioscience

Volumn 4, Issue 1, 2014, Pages

  He, Zhengyu ^a   Deng, Yuxiao ^a   Li, Wen ^a   Chen, Yongming ^a   Xing, Shunpeng ^a   Zhao, Xianyuan ^a   Ding, Jia ^a   Gao, Yuan ^a   Wang, Xiangrui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Collagen; Glycogen synthase kinase 3beta; Lipopolysaccharide; Lung fibroblasts; Phosphatase and tensin homolog; Phosphoinositide3 kinase Akt pathway; Proliferation

Indexed keywords

LENTIVIRUS;

EID: 84891516560     PISSN: None     EISSN: 20453701     Source Type: Journal    
DOI: 10.1186/2045-3701-4-2     Document Type: Article

References (59)

1. Tasaka S, Ishizaka A. Pulmonary fibrosis caused by ARDS. Nippon Naika Gakkai Zasshi 2005, 94(6):1106-1111. 10.2169/naika.94.1106, 15997737.
2. Li LF, Liao SK, Huang CC, Hung MJ, Quinn DA. Serine/threonine kinase-protein kinase B and extracellular signal-regulated kinase regulate ventilator-induced pulmonary fibrosis after bleomycin-induced acute lung injury: a prospective, controlled animal experiment. Crit Care 2008, 12(4):R103. 10.1186/cc6983, 2575592, 18691424.
3. Nobauer-Huhmann IM, Eibenberger K, Schaefer-Prokop C, Steltzer H, Schlick W, Strasser K, Fridrich P, Herold CJ. Changes in lung parenchyma after acute respiratory distress syndrome (ARDS): assessment with high-resolution computed tomography. Eur Radiol 2001, 11(12):2436-2443. 10.1007/s003300101103, 11734936.
4. Ito T, Kusunoki S, Kawamoto M. Case of transfusion-related acute lung injury associated with severe intraoperative hypoxemia. Masui 2008, 57(10):1265-1268.
5. Churg A, Muller NL, Silva CI, Wright JL. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am J Surg Pathol 2007, 31(2):277-284. 10.1097/01.pas.0000213341.70852.9d, 17255773.
6. Synenki L, Chandel NS, Budinger GR, Donnelly HK, Topin J, Eisenbart J, Jovanovic B, Jain M. Bronchoalveolar lavage fluid from patients with acute lung injury/acute respiratory distress syndrome induces myofibroblast differentiation. Crit Care Med 2007, 35(3):842-848. 10.1097/01.CCM.0000257254.87984.69, 17255860.
7. Rehan V, Torday J. Hyperoxia augments pulmonary lipofibroblast-to-myofibroblast transdifferentiation. Cell Biochem Biophys 2003, 38(3):239-250. 10.1385/CBB:38:3:239, 12794266.
8. Tian J, Wang Y, He Z, Gao Y, Rundhaug JE, Wang X. Hydroxyethyl starch (130 kD) inhibits toll-like receptor 4 signaling pathways in Rat lungs challenged with lipopolysaccharide. Anesth Analg 2011, 113(1):112-119. 10.1213/ANE.0b013e3182159c15, 21415432.
9. He Z, Zhu Y, Jiang H. Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study. Respir Res 2009, 10(1):126. 10.1186/1465-9921-10-126, 2803172, 20017955.
10. Takemura A, Matsuda N, Kimura S, Fujiwara T, Nakagawa I, Hamada S. Porphyromonas gingivalis lipopolysaccharide modulates the responsiveness of human periodontal ligament fibroblasts to platelet-derived growth factor. J Periodontal Res 1998, 33(7):400-407.
11. Kim JH, Lee G, Cho YL, Kim CK, Han S, Lee H, Choi JS, Choe J, Won MH, Kwon YG, et al. Desmethylanhydroicaritin inhibits NF-kappa B-regulated inflammatory gene expression by modulating the redox-sensitive PI3K/PTEN/Akt pathway. Eur J Pharmacol 2009, 602(2-3):422-431.
12. Kim JH, Na HJ, Kim CK, Kim JY, Ha KS, Lee H, Chung HT, Kwon HJ, Kwon YG, Kim YM. The non-provitarnin A carotenoid, lutein, inhibits NF-kappa B-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase/PTEN/Akt and NF-kappa B-inducing kinase pathways: Role of H2O2 in NF-kappa B activation. Free Radic Biol Med 2008, 45(6):885-896. 10.1016/j.freeradbiomed.2008.06.019, 18620044.
13. Maehama T. Regulation of the lipid phosphatase PTEN. Seikagaku 2006, 78(2):133-137.
14. Yamada KM, Araki M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J Cell Sci 2001, 114(Pt 13):2375-2382.
15. Fagone E, Conte E, Gili E, Fruciano M, Pistorio MP, Lo Furno D, Giuffrida R, Crimi N, Vancheri C. Resveratrol inhibits transforming growth factor-beta-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration. Exp Lung Res 2011, 37(3):162-174. 10.3109/01902148.2010.524722, 21269063.
16. Lammi L, Ryhanen L, Lakari E, Risteli J, Paakko P, Kahlos K, Lahde S, Kinnula V. Type III and type I procollagen markers in fibrosing alveolitis. Am J Respir Crit Care Med 1999, 159(3):818-823. 10.1164/ajrccm.159.3.9805060, 10051256.
17. Cesta MF, Ryman-Rasmussen JP, Wallace DG, Masinde T, Hurlburt G, Taylor AJ, Bonner JC. Bacterial lipopolysaccharide enhances PDGF signaling and pulmonary fibrosis in rats exposed to carbon nanotubes. Am J Respir Cell Mol Biol 2010, 43(2):142-151. 10.1165/rcmb.2009-0113OC, 2937228, 19738159.
18. Xia H, Diebold D, Nho R, Perlman D, Kleidon J, Kahm J, Avdulov S, Peterson M, Nerva J, Bitterman P, et al. Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis. J Exp Med 2008, 205(7):1659-1672. 10.1084/jem.20080001, 2442643, 18541712.
19. Wan X, Yokoyama Y, Shinohara A, Takahashi Y, Tamaya T. PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K/Akt signaling pathway. Cell Death Differ 2002, 9(4):414-420. 10.1038/sj.cdd.4400982, 11965494.
20. Xu Z, Stokoe D, Kane LP, Weiss A. The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells. Cell Growth Differ 2002, 13(7):285-296.
21. Beckner ME, Gobbel GT, Abounader R, Burovic F, Agostino NR, Laterra J, Pollack IF. Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis. Lab Invest 2005, 85(12):1457-1470.
22. Bouali S, Chretien AS, Ramacci C, Rouyer M, Becuwe P, Merlin JL. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells. Oncol Rep 2009, 21(3):731-735.
23. Barata JT. The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival. Adv Enzyme Regul 2011, 51(1):37-49. 10.1016/j.advenzreg.2010.09.012, 21035501.
24. Georgescu MM. PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control. Genes Cancer 2010, 1(12):1170-1177. 10.1177/1947601911407325, 3092286, 21779440.
25. Hamada K, Sasaki T, Koni PA, Natsui M, Kishimoto H, Sasaki J, Yajima N, Horie Y, Hasegawa G, Naito M, et al. The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev 2005, 19(17):2054-2065. 10.1101/gad.1308805, 1199575, 16107612.
26. Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW, Holland EC. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 2009, 4(3):226-235. 10.1016/j.stem.2009.01.007, 3688060, 19265662.
27. Han JS, Zhang XL, Liu XJ, An JY, Guo J, Zheng LB. Effects of PTEN gene silencing on collagen metabolism of activated hepatic stellate cells in vitro. J Gastroenterol Hepatol 2011, 26:154-154.
28. Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 2008, 8(3):187-198. 10.2174/156800908784293659, 18473732.
29. Liu YW, Chen CC, Wang JM, Chang WC, Huang YC, Chung SY, Chen BK, Hung JJ. Role of transcriptional factors Sp1, c-Rel, and c-Jun in LPS-induced C/EBPdelta gene expression of mouse macrophages. Cell Mol Life Sci 2007, 64(24):3282-3294. 10.1007/s00018-007-7375-5, 17965828.
30. Sharif O, Bolshakov VN, Raines S, Newham P, Perkins ND. Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immunol 2007, 8:1. 10.1186/1471-2172-8-1, 1781469, 17222336.
31. Meng LQ, Shelton CC, Li Y, Maki RG, Brill ER, Singer S, Schwartz GK, RD Association of Notch signaling pathway expression in liposarcomas with outcome, and targeting with outcome, and targeting with gamma-secretase inhibitors gamma-secretase inhibitors. J Clin Oncol 2009, 27(15s):10526. RD.
32. Hou P, Ji M, Xing M. Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors. Cancer 2008, 113(9):2440-2447. 10.1002/cncr.23869, 18831514.
33. Li TYY, Li X, Xu C, Meng L. EGFR- and AKT-mediated reduction in PTEN expression contributes to tyrphostin resistance and is reversed by mTOR inhibition in endometrial cancer cells. Mol Cell Biochem 2012, 361(1-2):19-29.
34. Zhu D, Hensel J, Hilgraf R, Abbasian M, Pornillos O, Deyanat-Yazdi G, Hua XH, Cox S. Inhibition of protein kinase CK2 expression and activity blocks tumor cell growth. Mol Cell Biochem 2010, 333(1-2):159-167.
35. Lee SH, Lee YP, Kim SY, Jeong MS, Lee MJ, Kang HW, Jeong HJ, Kim DW, Sohn EJ, Jang SH, et al. Inhibition of LPS-induced cyclooxygenase 2 and nitric oxide production by transduced PEP-1-PTEN fusion protein in Raw 264.7 macrophage cells. Exp Mol Med 2008, 40(6):629-638. 10.3858/emm.2008.40.6.629, 2679345, 19116448.
36. Wang CR, Shiau AL, Chen SY, Lin LL, Tai MH, Shieh GS, Lin PR, Yo YT, Lee CH, Kuo SM, et al. Amelioration of collagen-induced arthritis in rats by adenovirus-mediated PTEN gene transfer. Arthritis Rheum 2008, 58(6):1650-1656. 10.1002/art.23517, 18512785.
37. Gorbenko O, Kuznetsov V, Kukharenko O, Zhyvoloup A, Panasyuk G, Nemazanyy I, Filonenko V, Gout I. Identification of a novel binding partners for tumor suppressor PTEN by a yeast two-hybrid approach. Eksp Onkol 2004, 26(1):15-19.
38. Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA 1999, 96(11):6199-6204. 10.1073/pnas.96.11.6199, 26859, 10339565.
39. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 1999, 96(8):4240-4245. 10.1073/pnas.96.8.4240, 33561, 10200246.
40. Carracedo A, Pandolfi PP. The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene 2008, 27(41):5527-5541. 10.1038/onc.2008.247, 18794886.
41. He ZY, Zhu YS, Jiang H. Toll-like receptor 4 mediates lipopolysaccharide-induced collagen secretion by phosphoinositide3-kinase-akt pathway in fibroblasts during acute lung injury. J Recept Signal Transduct 2009, 29(2):119-125.
42. Shen Y, Zhang Q, Gao X, Ding F. An active fraction of achyranthes bidentata polypeptides prevents apoptosis induced by serum deprivation in SH-SY5Y cells through activation of PI3K/Akt/Gsk3 beta pathways. Neurochem Res 2011, 36(11):2186-2194. 10.1007/s11064-011-0543-x, 21735136.
43. X-l C, K-h R, H-w H, R-g S. Involvement of PI3K/AKT/GSK3 beta pathway in tetrandrine-induced G(1) arrest and apoptosis. Cancer Biol Ther 2008, 7(7):1073-1078. 10.4161/cbt.7.7.6142, 18437054.
44. Yoon K, Jung EJ, Lee SY. TRAF6-mediated regulation of the PI3 kinase (PI3K)-Akt-GSK3 beta cascade is required for TNF-induced cell survival. Biochem Biophys Res Commun 2008, 371(1):118-121. 10.1016/j.bbrc.2008.04.007, 18407828.
45. Rudler M, Tazi KA, Galbois A, Mohammadi MS, Lebrec D, Moreau R. Upregulated glycogen synthase kinase3-beta (GSK3-beta) plays a major role in toll-like receptor (TLR)-mediated hyperproduction of proinflammatory cytokines in monocytes from patients with cirrhosis. Hepatology 2006, 44(4):353A-353A.
46. Gustot T, Rudler M, Coant N, Gandoura S, Guichard C, Abdel-Razek W, Ragot K, Galbois A, Tellier Z, Lizard GH, et al. Unrestricted constitutive activity of glycogen synthase kinase 3 (gsk3) inhibits anti-inflammatory and favors pro-inflammatory cytokine production in lps-stimulated immune cells from patients with advanced cirrhosis. Hepatology 2009, 50(4):873A-873A.
47. Gustot T, Simon-Rudler M, Fasseu M, Gandoura S, Abdel-Razek W, Deviere J, Lebrec D, Moreau R. Glycogen synthase kinase 3 (gsk3) in immune cells is a major player intlr4-mediated cytokine storm in patients with advanced cirrhosis. J Hepatol 2010, 52:S207-S208.
48. He Z, Gao Y, Deng Y, Li W, Chen Y, Xing S, Zhao X, Ding J, Wang X. Lipopolysaccharide induces lung fibroblast proliferation through toll-like receptor 4 signaling and the Phosphoinositide3-kinase-Akt pathway. PLoS ONE 2012, 7(4):e35926. 10.1371/journal.pone.0035926, 3338545, 22563417.
49. Eng CH, Huckaba TM, Gundersen GG. The formin mDia regulates GSK3beta through novel PKCs to promote microtubule stabilization but not MTOC reorientation in migrating fibroblasts. Mol Biol Cell 2006, 17(12):5004-5016. 10.1091/mbc.E05-10-0914, 1679669, 16987962.
50. Rosivatz E, Matthews JG, McDonald NQ, Mulet X, Ho KK, Lossi N, Schmid AC, Mirabelli M, Pomeranz KM, Erneux C, et al. A small molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN). ACS Chem Biol 2006, 1(12):780-790. 10.1021/cb600352f, 17240976.
51. DA Akca H, Tokgun O, Yokota J. Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K/AKT/NFkB pathway in lung cancer cells. Lung Cancer 2011, 73(3):302-309. 10.1016/j.lungcan.2011.01.012, 21333374.
52. Potter CJ, Pedraza LG, Xu T. Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 2002, 4(9):658-665. 10.1038/ncb840, 12172554.
53. Sancak YTC, Peterson TR, Lindquist RA, Kang SA, Spooner E, Carr SA, Sabatini DM. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 2007, 25(6):903-915. 10.1016/j.molcel.2007.03.003, 17386266.
54. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307(5712):1098-1101. 10.1126/science.1106148, 15718470.
55. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378(6559):785-789. 10.1038/378785a0, 8524413.
56. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96(6):857-868. 10.1016/S0092-8674(00)80595-4, 10102273.
57. He Z, Zhu Y, Jiang H. Toll-like receptor 4 mediates lipopolysaccharide-induced collagen secretion by phosphoinositide3-kinase-Akt pathway in fibroblasts during acute lung injury. J Recept Signal Transduct Res 2009, 29(2):119-125. 10.1080/10799890902845690, 19519177.
58. Taylor GS, Dixon JE. PTEN and myotubularins: families of phosphoinositide phosphatases. Methods Enzymol 2003, 366:43-56.
59. Jules Meijerink CM, van de Locht L, Tönnissen E, Goodsaid F, Raemaekers J. A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR. J Mol Diagn 2001, 3(2):55-61. 10.1016/S1525-1578(10)60652-6, 1910699, 11333300.